Topivert Pharma
Pharmaceutical Manufacturing · 11 Employees
Email Address: info@topivert.com
- Overview
- Employees
Access 2 Verified Employees Profiles for Topivert PharmaUnlock Free Contacts Now
About
TopiVert is a clinical-stage biotechnology company developing next-generation, Narrow Spectrum Kinase Inhibitors (NSKIs) as novel, non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal (GI) tract and the eye. The lead GI programme TOP1288 is currently in a Phase IIa proof of concept study in ulcerative colitis. A Phase I/II study with TOP1630 for dry eye syndrome will commence in the US in early 2017.
Website
Year Founded
2011
Social Media
LinkedinTwitter
Industry
Pharmaceutical Manufacturing
HQ Location
265 Strand
London, WC2R 1BH, GB
Keywords
NSKIulcerative colitiskinase inhibitorsand ophthalmology
Location
- 265 Strand London, WC2R 1BH, GB
Email Formats
Sign up for free credits and discover verified email addresses of Topivert Pharma
FormatExamples
first + last
andywarhol@topivert.com
first_initial + last
awarhol@topivert.com
first + last_initial
andyw@topivert.com
first
andy@topivert.com
last
warhol@topivert.com
Frequently Asked Questions
Key Contacts
Similar Companies
Pharmaceutical Manufacturing
Get key business info for Topivert Pharma and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.